Description

Suzuki et al evaluated patients with surgically resected non-small cell lung carcinoma based on prognostic features selected for each tumor stage. This can help better individualize the survival prediction. The authors are from the National Cancer Hospital in Tokyo and the National Cancer Hospital in Chiba, Japan.


 

Patient selection: adenocarcinoma, squamous cell carcinoma, other (large cell undifferentiated carcinoma, etc.)

 

Stage

Favorable Prognostic Factors

I

N0 or N1; no vascular invasion, completely resected

II, III or IV

N0 or N1; not an adenocarcinoma; small tumor size; completely resected

from Table 2 and Table 5

 

Patients with Stage IV disease had a dismal prognosis only a small percentage surviving more than 1 year.

 

Stage

Finding 1

Finding 2

Probability of 5 Year Survival

I

N0 or N1

no vascular invasion

92%

I

N2

no vascular invasion

72%

I

N0 or N1

vascular invasion

72%

I

N2

vascular invasion

21%

II

not adenocarcinoma

<= 3 cm

88%

II

adenocarcinoma

<= 3 cm

76%

II

not adenocarcinoma

> 3 cm

76%

II

adenocarcinoma

> 3 cm

25%

IIIA

<= 3 cm

 

48%

IIIA

> 3 cm

 

22%

IIIB

N0 or N1

complete resect

72%

IIIB

N0 or N1

incomplete

18%

IIIB

N2 or N3

complete resect

18%

IIIB

N2 or N3

incomplete

10%

 

where:

• Complete resection indicates a negative surgical margin and the highest mediastinal lymph node negative for tumor.

• Incomplete resection indicates a positive surgical margin and/or the highest mediastinal lymph node positive for tumor.

• A Stage IIIB tumor with N0 or N1 has to be a T4 lesion.

 


To read more or access our algorithms and calculators, please log in or register.